Sputnik V’s development has been marked by worrying opacity and ethical issues
The race to find a vaccine against Covid-19 has not always been particularly edifying, driven at times by so-called “vaccine nationalism”, much cautioned against by the World Health Organization, which has itself been accused of being invested as much in self-interest and prestige as global public health.
Russia’s announcement that it has registered its Sputnik V vaccine as safe and effective for mass production and inoculation even before so-called phase 3 large-scale safety trials, which usually take months, fits the pattern.
Get your custom MOON reading
